Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410132 | SCV000486190 | likely pathogenic | Megalencephalic leukoencephalopathy with subcortical cysts 1 | 2016-04-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001380083 | SCV001578026 | pathogenic | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys46Alafs*12) in the MLC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MLC1 are known to be pathogenic (PMID: 11254442, 16470554, 24824219). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with megalencephalic leukoencephalopathy with subcortical cysts (PMID: 19168821). ClinVar contains an entry for this variant (Variation ID: 370785). For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV000410132 | SCV003806884 | pathogenic | Megalencephalic leukoencephalopathy with subcortical cysts 1 | 2022-07-04 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PS4 moderated, PM2 moderated, PM3 supporting |
Baylor Genetics | RCV000410132 | SCV004195001 | pathogenic | Megalencephalic leukoencephalopathy with subcortical cysts 1 | 2023-02-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833490 | SCV002081609 | pathogenic | Megalencephalic leukoencephalopathy with subcortical cysts | 2020-09-29 | no assertion criteria provided | clinical testing |